Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

In a nutshell Scientists used magnetic brain stimulation to restore damaged connections in mice with Alzheimer’s-like ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

Vision Tests Could Diagnose Dementia 12 Years Earlier Than Usual, Says Research Dementia is an incurable ailment that ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Researchers have developed a blood test that detects Alzheimer's biomarkers at single-molecule levels, enabling earlier, ...

Life Molecular Imaging, Ltd. (LMI) announced that the U.S. Food and Drug Administration (FDA) has approved updated labeling for Neuraceq® (florbetaben F18 injection), expanding its indication for ...

According to the Alzheimer’s Association, more than 120,000 Missourians are living with the disease. But a newly approved ...

New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...